Marcel Kloosterman

Marcel Kloosterman


Marcel has been active in venture capital since 2004. His fields of interest and expertise span the areas of life sciences and cleantech.

He is Director of Chemelot Ventures and senior investment manager of its predecessor Limburg Ventures. Up to 2016 he was Investment Manager with DSM Venturing. In these capacities he was involved in a large number of investments and acting as a board member, limited partner and/or shareholder for multiple portfolio companies.

He is currently member of the board of ACS Biomarker BV, Mirnext BV, Cristal Therapeutics BV, Matisse Pharmacueticals BV, TripleMed BV, Beirats member of Nano4Imaging GmbH and shareholder representative of Bioactor BV and Enzypep BV. Marcel was a former board member of Q Chip Ltd prior to its merger and IPO.

Marcel is active in various European advisory board councils, investment committees and jury panels. Before his involvement in venture capital Marcel held various management functions in market research, emerging technologies, new business development and new business creation to corporate secretary.

He has a PhD in organic chemistry from Leiden University (Netherlands).